Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

Kissling, Esther; (...); Ilić, Maja; (...); Kurečić Filipović, Sanja; (...); Valenciano, Marta; I-MOVE- COVID-19 and ECDC primary care study teams

doi:10.2807/1560-7917.ES.2022.27.21.2101104

Pregled bibliografske jedinice broj: 1198322

Effectiveness of complete primary vaccination against COVID- 19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE- COVID-19 and ECDC networks, July to August 2021

Kissling, Esther; (...); Ilić, Maja; (...); Kurečić Filipović, Sanja; (...); Valenciano, Marta; I-MOVE- COVID-19 and ECDC primary care study teams

Effectiveness of complete primary vaccination against COVID- 19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE- COVID-19 and ECDC networks, July to August 2021 // Eurosurveillance, 27 (2022), 21; 7-19 doi:10.2807/1560-7917.ES.2022.27.21.2101104 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1198322 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Effectiveness of complete primary vaccination against COVID- 19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE- COVID-19 and ECDC networks, July to August 2021
(Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021)

Autori
Kissling, Esther ; (...) ; Ilić, Maja ; (...) ; Kurečić Filipović, Sanja ; (...) ; Valenciano, Marta ; I-MOVE- COVID-19 and ECDC primary care study teams

Izvornik
Eurosurveillance (1025-496X) 27 (2022), 21; 7-19

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
COVID-19 ; Delta variant ; Europe ; SARS-COV-2 ; multicentre study ; vaccine efffectiveness

Sažetak
Using a multicentre test-negative study, we measured COVID-19 vaccine effectiveness (VE) against symptomatic infection. VE against symptomatic infection with SARS-CoV-2 Delta variant varied among brend, ranging from 52% to 91%.

Izvorni jezik
Engleski

Znanstvena područja
Javno zdravstvo i zdravstvena zaštita

Napomena
I-MOVE-COVID-19 and ECDC primary care study team
(in
addition to authors above): Katica Čusek Adamić,
Ivana
Ferenčak, Bernard Kaić, Mirjana Lana Kosanović
Ličina,
Danijela Lakošeljac, Ivana Mihin Huskić, Diana
Nonković ...

POVEZANOST RADA

Ustanove:
Hrvatski zavod za javno zdravstvo

Profili:

Ivana Ferenčak (autor)